ISN-ASN 2025 Meeting
CONFERENCE 2025-08-19 00:00:00-2025-08-22 00:00:00 New York, New York 19 – 22 August 2025 View Conference Website 0
340467 RESULTS
CONFERENCE 2025-08-19 00:00:00-2025-08-22 00:00:00 New York, New York 19 – 22 August 2025 View Conference Website 0
CONFERENCE 2025-08-14 00:00:00-2025-08-18 00:00:00 New York, New York 14 – 18 August 2025 Opportunity for young neurochemists to meet experts and other graduate students. Application period ends 15 November 2024. View Conference Website 0
PAPER Lorenz B, Münkner J, Oliveira MP, Kuusksalu A, Leitão JM, Müller WE, Schröder HC
COMMENT Bruce had a brilliant career in both academia and industry and left an indelible mark on the Alzheimer’s disease drug development landscape. He led drug development efforts in several companies, most notably at Eisai, where he directed their BACE inhibito
COMMENT It was with shock and incredible sadness that colleagues at Eisai received the news that Bruce Albala had passed away. Bruce was a senior member of the neurology clinical development department at Eisai from 2010 to 2019, where he led the development of e
COMMENT I am saddened by the sudden and much too early death of Bruce Albala. Bruce was an excellent scientist, a great colleague, a good friend, and a leading scientist in the development of BACE inhibitors for Alzheimer’s disease. Working with Eisai, Bruce was
COMMUNITY NEWS 2024-11-08 Community News Scientists in industry and academia were shocked and saddened to hear of the sudden passing of Bruce Albala. Albala died in Greece on October 16 while celebrating his 40th wedding anniversary with his wife. “The AD community, and especially
JOB 2024-11-08 Employer University of California San Diego Contact To apply, please visit: https://apptrkr.com/5784747 Document requirements Curriculum Vitae- Your most recently updated C.V. Cover Letter Statement of Contributions to Diversity- Applicants should summari
JOB 2024-11-08 Employer Massachusetts General Hospital Principal Investigator Teresa Gomez-Isla Contact Applicants are required to submit the following documents to the program director for consideration: Cover letter, research statement (optional: two pages maximum), C
Eisai LimitedUnited Kingdom
PAPER Lagerlöf O, Hart GW, Huganir RL
Eisai LimitedLondon, United Kingdom
Frontiers in DementiaUnited Kingdom
PAPER Tan L, Xie J, Liao C, Li X, Zhang W, Cai C, Cheng L, Wang X
PAPER Wu B, Li S, Han W
No filters selected